Short Course  |  Day 1  |  Day 2

MONDAY, JUNE 8

RECOMMENDED PRE-CONFERENCE SHORT COURSE*

2:00 – 5:00 pm
(SC5) COLLABORATING TO ACCELERATE THE ADOPTION OF NOVEL TECHNOLOGIES IN THE PRECLINICAL R&D PROCESS
How much does the ‘Not Invented Here’ mentality inhibit new technology assessment/implementation in your organization?
What can be done to lower the barriers for new technology or novel platform adoption?
Can we simplify the technology evaluation process?
Collaborative projects - Is this the solution?
This course provides you with benchmark data techniques to use collaboration options to more efficiently adopt novel technologies.
Course Instructors: Ernie Bush, Ph.D., Vice President,
Collaborative Projects, Drug Safety Executive Council
Judith Marquis, Ph.D., Group Vice President, Pharmacology and Preclinical Development, Genzyme
George McCormick, Ph.D., Vice President, Drug Safety & Disposition, Cephalon
Jack Reynolds, Ph.D., Chairman, Advisory Board, Drug Safety Executive Council

*Separate Registration Required

Drug Safety Executive Council

The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of drug safety leaders with the common objective of advancing the development of better and safer medicines worldwide. Membership in DSEC is limited to leaders representing companies who develop small and large molecule pharmaceuticals only.